HKScan Corporation STOCK EXCHANGE RELEASE, 5 November 2007 at 4pm ANIMAL DISEASE CONFIRMED IN ESTONIAN EGG PRODUCTION The animal disease suspected at an egg farm operated by HKScan's Estonian subsidiary Tallegg has been confirmed by the authorities as Newcastle disease. All hens at the farm will therefore be destroyed and the premises cleaned and disinfected. The measures will be implemented together with the Estonian veterinary authorities. Tallegg has suspended deliveries of eggs from its own production chain and put temporary arrangements in place to manage deliveries. Newcastle disease is an avian disease that is not transmissible to humans or other mammals. Tallegg markets eggs in Estonia and operates egg farms in the town of Külli. The disruption in Tallegg's egg production caused by the disease is likely to extend through the first half of the coming year. Egg production is estimated to reach 50% capacity in April and return to normal in summer. Egg production accounts for roughly 14% of Tallegg's net sales. Tallegg carries insurance against animal disease. The disruption in production is projected to have no significant financial impact. The destruction and disposal of the infected birds as well as the cleaning and disinfection of the farm premises will be handled by the Estonian state. The measures arising from the disease are restricted only to Tallegg's egg production. The company's broiler production is not affected in any way and will continue to operate normally. HKScan Corporation Kai Seikku CEO Further information: Olli Antniemi, executive vice president, HKScan Baltic Group +372 502 0929 DISTRIBUTION: OMX Nordic Exchanges Main media www.hkscan.com